Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PGNX > SEC Filings for PGNX > Form 8-K on 9-Aug-2013All Recent SEC Filings

Show all filings for PROGENICS PHARMACEUTICALS INC

Form 8-K for PROGENICS PHARMACEUTICALS INC


9-Aug-2013

Results of Operations and Financial Condition, Financial Statements


Item 2.02. Results of Operations and Financial Condition.

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced its operational results for the quarter and six months ended June 30, 2013. A copy of its press release is included in this Report as Exhibit 99.1.
The information furnished pursuant to this Item 2.02 shall not be deemed to be "filed" for purposes of Section 18 of the U.S. Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, unless we specifically incorporate it by reference in a document filed under the Exchange Act or the U.S. Securities Act of 1933. We undertake no duty or obligation to publicly update or revise the information so furnished. Item 8.01. Other Events.

Progenics is committed to providing current and accurate information about its business to stockholders, potential investors, the media and others interested in the Company. We understand that people look to the Internet, including Progenics' and the U.S. Securities and Exchange Commission's websites, general news and financial websites, and other sources for information, and that social media channels such as Facebook®, Twitter® and LinkedIn® are also useful and important information sources.
We are beginning to use social media such as LinkedIn (www.linkedin.com/company/30050) to complement our website (www.progenics.com), SEC filings, press releases, conference calls, webcasts and other public communications in disseminating business and financial information about Progenics. Some of this information could be deemed material non-public information at the time of disclosure, and some may constitute forward-looking statements.
We encourage stockholders, potential investors, the media and others interested in Progenics to visit conventional and social media platforms and websites to follow us. As we expand the spaces and ways in which we communicate with the public, we will note them on our website.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release dated August 9, 2013.


  Add PGNX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PGNX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.